First Phase III Data For Inovio's Immunotherapy VGX-3100 Encouraging In Cervical Dysplasia

Withdrawals Affect ITT But Not mITT Analysis

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.